To find out if RUNX1 can modulate TGFβ1 function in these processes, we performed various in vitro experiments and treated cancer cells with either recombinant TGFβ1 or co-cultured with hepatocyte (IHH) cells, upon RUNX1 inhibition. This evidence concerns the gene RUNX1 and cancer.